Abstract
I.v. administration of GYKI-52466, a non-competitive AMPA/kainate glutamatergic receptor antagonist, inhibited bladder contractions elicited by electrical stimulation in the pontine micturition center (PMC) in urethane-anesthetized rats. The mean threshold dose of GYKI-52466 was 2 mg/kg i.v. (range = 1-4 mg/kg). Maximum inhibition (mean = 57.7 +/- 8.2%, range = 24-83.3% of control) occurred at a dose of 8 mg/kg. CNQX, a competitive AMPA/kainate glutamatergic receptor antagonist, did not significantly alter the evoked contractions. These results indicate that AMPA/kainate receptors are involved in bulbospinal excitatory pathway from the PMC to the parasympathetic nucleus in the lumbosacral spinal cord in the rat.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Animals
-
Anti-Anxiety Agents*
-
Benzodiazepines / pharmacology
-
Dizocilpine Maleate / pharmacology
-
Dose-Response Relationship, Drug
-
Excitatory Amino Acid Antagonists / pharmacology
-
Female
-
Injections, Intravenous
-
Neural Pathways / physiology
-
Parasympathetic Nervous System / cytology
-
Parasympathetic Nervous System / physiology
-
Pons / physiology*
-
Rats
-
Rats, Wistar
-
Receptors, AMPA / physiology*
-
Receptors, Kainic Acid / physiology*
-
Receptors, N-Methyl-D-Aspartate / physiology
-
Spinal Cord / physiology*
-
Synaptic Transmission / physiology
-
Time Factors
-
Urinary Bladder / drug effects
-
Urinary Bladder / innervation
-
Urination / physiology*
Substances
-
Anti-Anxiety Agents
-
Excitatory Amino Acid Antagonists
-
Receptors, AMPA
-
Receptors, Kainic Acid
-
Receptors, N-Methyl-D-Aspartate
-
GYKI 52466
-
Benzodiazepines
-
Dizocilpine Maleate